Author:
Chen Ying,Shi Chunying,Guo Qiyong
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Chu D, Lu J. Novel therapies in breast cancer: what is new from ASCO 2008. J Hematol Oncol. 2008;1:16. doi: 10.1186/1756-8722-1-16 .
2. Hong W, Dong E. The past, present and future of breast cancer research in China. Cancer Lett. 2014. doi: 10.1016/j.canlet.2014.04.007 .
3. Ying-ji L, Xu-dong D, Xi-wen S, Hui-li H, Lu A-M, Lu Y, et al. The incidence and mortality analysis malignancies in 1995 and 2000 year in major cities of Heilongjiang Province. Bull Chin Cancer. 2002;11(1):29–30.
4. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature. 2007;447(7148):1087–93. doi: 10.1038/nature05887 .
5. Bayraktar S, Thompson PA, Yoo SY, Do KA, Sahin AA, Arun BK, et al. The relationship between eight GWAS-identified single-nucleotide polymorphisms and primary breast cancer outcomes. Oncologist. 2013;18(5):493–500. doi: 10.1634/theoncologist.2012-0419 .
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献